In this study, we show for the first time that in a large cohort of colon cancer samples, the mRNA of B4GALNT2 is dramatically down-regulated compared with normal tissue, consistent with previous observations of a reduced B4GALNT2 enzymatic activity in CRC tissues [8,10]. This evidence concerns the gene B4GALNT2 and malignant colon neoplasm.